1Analyzing priority challenges in China's vaccine regulation with the Hanlon methodWANG Ri-zhen, XU Ming, PAN Hai-long, ZUO Shu-yan, YUAN Yuan, HUANG Yang-mu673-6782Gastric organoids model reveals the host-pathogen interaction mechanism of Helicobacter pylori infection:from colonization mechanism to targeted therapyTIAN Shu-ting, ZHANG Lin-li, DENG Yi-fang679-6873The introduction and enlightenment of drug price management and the new price review framework in CanadaOU Yang-lu, HU Hong-fei, ZHOU Ting688-6944The complete response letter in FDA's review decision feedback mechanism and its implications for ChinaLU Jian, SHA Ming-quan, DONG Mei-yi, BAI Yu695-7005Research advances in key technologies and real-time quality control for quality by design-driven micrometer-scale tablet formulationsWU Lei, REN Peng-fei, YU Zhou-bo, LI Zhen-bo, HE Yu-xin, LIU Yi-han, YANG Jing, WANG Rui701-7096Current status and considerations on the control of ethylene glycol,diethylene glycol,and triethylene glycol impurities in pharmaceutical excipientsWANG Jue, WANG Xiao-feng, ZHANG Xue-yan, ZHAO Xia, NING Bao-ming, LING Xiao, TU Jia-sheng, YANG Rui, ZHANG Jun, SUN Hui-min710-7217Analysis and standardization strategies of serious adverse event reports in pediatric drug clinical trialsGUO Chun-yan, ZHANG Yi, YANG Yu-xin, LIANG Yu-guang, DING Qian, WANG Qian, ZHANG Meng, SONG Li-juan, ZHANG Cheng-yue, SUN Yu, GUO Peng722-7268Bibliometric analysis of AI technologies applied in drug clinical trials:perspectives from global and Chinese research domainsXIONG Xue-mei, GU Jin, HU Chen-xi, HUANG Yuan-kai, XU Hou-ming727-7339Simultaneous determination of 10 components in Puqin Jiedu Lishi granules by HPLC-PDA methodLI Shuai-yin, XI Hui-rong, CHEN Ting, LI Xi-xiang, LI Xiao-feng, ZHOU Ya-li, YANG Shou-yuan734-74010Exploring the therapeutic effects and underlying mechanisms of Tibetan medicine Xiaoboyuganzi decoction on type 2 diabetes mellitus via network pharmacologyTIAN Mei-gui, ZONG Yi, PENG Jia-yan, HUANG Xue-mei, XIONG Shuang-feng, ZHANG Jing, FAN Gang741-74811Study on crystal structure and crystal habit of tofacitinib enantiomerGUAN Hao-yue, SUN Jing-wen, NIU Jian-zhao749-75312Bioavailability study of five components of Yinqiao Qingre tablets in ratsTAN Yu-rong, YIN Ming-ke, FENG Jian, CHEN Xia-lin, WANG Dong-hui, WANG Jia-jia, CAO Liang, WANG Zhen-zhong, XIAO Wei, GAO Xia754-76313Signal mining of drug-related thyroid abnormalities using the FAERS databaseZHAO Jian-qun, WU Yu-pei, SHI Yan-shuo, YU Zeng-fang, MA Yin-ling764-77114Adverse event signal mining and serious adverse event influencing factor analysis of avacopan based on FAERS databaseLI Di, YE Xiao-chun, LI Lu-lu, ZHANG Shao-hui772-77915Successful correction of perioperative hypoalbuminemia with recombinant human albumin injection(Oryza Sativa)in a patient with allergy to human serum albumin:a case reportDiligeer·TAYIER, QIN Xian, LIAO Ru-fang, YANG Zhi-yong780-784 